D-荧光素钾盐(D-Luciferin Potassium Salt)引用文献合集与应用指南

D-荧光素钾盐(D-Luciferin Potassium Salt)引用文献合集与应用指南 - 武汉多找找科技

D-荧光素钾盐(D-Luciferin Potassium Salt)引用文献合集与应用指南

在小鼠活体成像(In Vivo Imaging System, IVIS)和体外生物发光检测中,D-荧光素钾盐(D-Luciferin Potassium Salt)作为荧光素酶(Luciferase)催化底物,凭借其高灵敏度和低背景噪音特性,已成为肿瘤转移追踪、CAR-T免疫治疗效果评估及基因表达监测不可或缺的生物化学试剂。

美国 Syd Labs 生产的高纯度D-荧光素钾盐(货号:MB102 或 MB000102-R70170,CAS号:115144-35-9,纯度>99% HPLC),多年来被全球众多顶尖高校与科研机构的核心实验室(Core Facilities)采购与持续复购。截至目前,已有 107 篇高水平SCI学术文献(发表于 Nature Communications, Cancer Discovery, eLife, Advanced Science 等顶级期刊)引用并证实了其卓越的生物发光性能与质量稳定性(文献库持续更新中):

Syd Labs D-荧光素钾盐权威引用文献合集(全107篇)

  1. Aging of mice is associated with p16 (Ink4a)-and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells. Brandon M Hall, et al. Aging (Albany NY). 2016. PMCID: PMC4993332
  2. Murine mesenchymal cells that express elevated levels of the CDK inhibitor p16(Ink4a) in vivo are not necessarily senescent. David Frescas, et al. Cell Cycle. 2017. PMCID: PMC5584871
  3. p16 (Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli. Brandon M Hall, et al. Aging (Albany NY). 2017. PMCID: PMC5611982
  4. Induction of a tier-1-like phenotype in diverse tier-2 isolates by agents that guide HIV-1 Env to perturbation-sensitive, nonnative states. Jacklyn Johnson, et al. J Virol. 2017. PMCID: PMC5512248
  5. Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model. Orlando DeLeon, et al. PLoS Biol. 2017. PMCID: PMC5383018
  6. Interleukin-17 promotes metastasis in an immunocompetent orthotopic mouse model of prostate cancer. David Cunningham, et al. Am J Clin Exp Urol. 2018. PMCID: PMC6055074
  7. Multimodality cellular and molecular imaging of concomitant tumour enhancement in a syngeneic mouse model of breast cancer metastasis. Katie M Parkins, et al. Sci Rep. 2018. PMCID: PMC5997674
  8. Nontoxic targeting of energy metabolism in preclinical VM-M3 experimental glioblastoma. Zachary M Augur, et al. Front Nutr. 2018. PMCID: PMC6186985
  9. Inhibition of yes‑associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model. Ping‑Chih Hsu, et al. J Cell Mol Med. 2018. PMCID: PMC5980132
  10. Cellular MRI reveals altered brain arrest of genetically engineered metastatic breast cancer cells. Katie M Parkins, et al. Contrast Media Mol Imaging. 2019. PMCID: PMC6348811
  11. Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model. Ping-Chih Hsu, et al. Oncol Rep. 2019. PMCID: PMC6610039
  12. Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function. Hillary G Caruso, et al. J Neurooncol. 2019. PMID: 31686330
  13. The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies. Zofia Pilch, et al. PLoS One. 2019. PMCID: PMC6336379
  14. Circulating tumor cells exhibit metastatic tropism and reveal brain metastasis drivers. Remi Klotz, et al. Cancer Discov. 2019. PMCID: PMC6954305
  15. Properties of HIV-1 env and human seminal fluid that determine virus inhibition by antibodies and microbicides. Johnson, Jacklyn, et al. Summer 2019.
  16. Th17 cells promote tumor growth in an immunocompetent orthotopic mouse model of prostate cancer. Zhenling Duan, et al. Am J Clin Exp Urol. 2019. PMCID: PMC6734037
  17. Thermosensitive alternative splicing senses and mediates temperature adaptation in Drosophila. Ane Martin Anduaga, et al. eLife. 2019. PMCID: PMC6890466
  18. Cucurbitacin E inhibits the Yes-associated protein signaling pathway and suppresses brain metastasis of human non-small cell lung cancer in a murine model. Ping-Chih Hsu, et al. Oncol Rep. 2019. PMCID: PMC6610039
  19. LINE1 derepression in aged wild type and SIRT6 deficient mice drives inflammation. Matthew Simon, et al. Cell Metab. 2019. PMCID: PMC6449196
  20. Engineering Circulating Tumor Cells as Novel Cancer Theranostics. Katie M Parkins, et al. Theranostics. 2020. PMCID: PMC7359075
  21. Local targeting of lung-tumor-associated macrophages with pulmonary delivery of a CSF-1R inhibitor for the treatment of breast cancer lung metastases. Sulaiman S Alhudaithi, et al. Mol Pharm. 2020. PMCID: PMC8060921
  22. The fusion peptide proximal region of the HIV-1 envelope glycoproteins regulates exposure of immunogenic epitopes at the trimer base. Hillel Haim, et al. bioRxiv. 2020.
  23. Engineering “self-homing” circulating tumour cells as novel cancer theranostics. Katie M Parkins, et al. Theranostics. 2020. PMCID: PMC7359075
  24. Tumor-responsive, multifunctional CAR-NK cells cooperate with impaired autophagy to infiltrate and target glioblastoma. Jiao Wang, et al. bioRxiv. 2020.
  25. Intra-arterial injection to create bone metastasis of prostate cancer in mice. Lin Zhong, et al. Am J Clin Exp Urol. 2020. PMCID: PMC7486538
  26. Local Targeting of Lung Tumor Associated Macrophages with Pulmonary Delivery of a CSF-1R Inhibitor for the Treatment of Breast Cancer Lung Metastases. Sulaiman S Alhudaithi, et al. Mol Pharm. 2020. PMCID: PMC8060921
  27. Phosphatidylserine receptors enhance SARS-CoV-2 infection. Dana Bohan, et al. PLoS Pathog. 2021. PMCID: PMC8641883
  28. Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI. Veronica P Dubois, et al. Mol Imaging Biol. 2021. PMCID: PMC8983548
  29. Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment. Er Yue, et al. Cancers (Basel). 2021. PMCID: PMC8428227
  30. Pulmonary administration of a CSF-1R inhibitor alters the balance of tumor-associated macrophages and supports first-line chemotherapy in a lung cancer model. Hanming Zhang, et al. Int J Pharm. 2021. PMID: 33545279
  31. Inhibition of aberrant tissue remodelling by mesenchymal stromal cells singly coated with soft gels presenting defined chemomechanical cues. Sing Wan Wong, et al. Nat Biomed Eng. 2021. PMCID: PMC8908879
  32. Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy. Zhefu Dai, et al. J Control Release. 2021. PMCID: PMC8373670
  33. PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress. Marta Klopotowska, et al. Cancer Immunol Res. 2021. PMCID: PMC9414282
  34. Modular cell-assembled adipose matrix-derived bead foams as a mesenchymal stromal cell delivery platform for soft tissue regeneration. Pascal Morissette Martin, et al. Biomaterials. 2021. PMID: 34182328
  35. Site-Specific Antibody-Drug Conjugates with Variable Drug-to-Antibody-Ratios for Acute Myeloid Leukemia Therapy. Zhefu Dai, et al. J Control Release. 2021. PMCID: PMC8373670
  36. Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice. Maho Kawaguchi, et al. J Pharm Sci. 2022. PMCID: PMC9805379
  37. Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability. Mariko Kamiya, et al. Pharmaceutics. 2022. PMCID: PMC9697436
  38. Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors. Andrea M Chambers, et al. eLife. 2022. PMCID: PMC9342955
  39. Anti-tumor antibody isotype response can be modified with locally administered immunoadjuvants. Adam A Walters, et al. Drug Deliv Transl Res. 2022. PMCID: PMC10238356
  40. Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles. Xuefeng Li, et al. Nat Nanotechnol. 2022. PMCID: PMC9378430
  41. Development of highly effective anti-mesothelin hYP218 chimeric antigen receptor T cells with increased tumor infiltration and persistence for treating solid tumors. Sakshi Tomar, et al. Mol Cancer Ther. 2022. PMCID: PMC9256778
  42. Dormant senescence-prone cells (DSPC): a lifetime memory about systemic genotoxic stress. Andrei Gudkov, et al. Research Square. 2022.
  43. Commonly elicited antibodies against the base of the HIV-1 Env trimer guide the population-level evolution of a structure-regulating region in gp41. Hillel Haim, et al. J Virol. 2022. PMCID: PMC9278142
  44. A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis. Lucía Zhu, et al. EMBO Mol Med. 2022. PMCID: PMC8899920
  45. Limited variation between SARS-CoV-2-infected individuals in domain specificity and relative potency of the antibody response against the spike glycoprotein. Hanora A Van Ert, et al. Microbiol Spectr. 2022. PMCID: PMC8791189
  46. A drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent local relapse and treat established brain metastasis. Lucía Zhu, et al. EMBO Mol Med. 2022. PMCID: PMC8899920
  47. Cryopreservation of Plasmodium Sporozoites. Carson Bowers, et al. Pathogens. 2022. PMCID: PMC9784981
  48. A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis. Lucía Zhu, et al. EMBO Mol Med. 2022. PMCID: PMC8899920
  49. Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias. Elisaveta Voynova, et al. Cancers (Basel). 2022. PMCID: PMC8833462
  50. Anti-Trypanosoma cruzi activity of Coptis rhizome extract and its constituents. Yuki Tayama, et al. Trop Med Health. 2023. PMCID: PMC9976467
  51. Induction of liver-resident memory T cells and protection at liver-stage malaria by mRNA-containing lipid nanoparticles. Sayuri Nakamae, et al. Front Immunol. 2023. PMCID: PMC10482405
  52. Glycolysis regulates KRAS plasma membrane localization and function through defined glycosphingolipids. Junchen Liu, et al. Nat Commun. 2023. PMCID: PMC9884228
  53. A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin. Jiyong Liang, et al. Cancers (Basel). 2023. PMCID: PMC9953964
  54. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery. Yue Qin, et al. Biomaterials. 2023. PMID: 37243988
  55. Influence of lipid composition of messenger RNA-loaded lipid nanoparticles on the protein expression via intratracheal administration in mice. Longjian Geng, et al. Int J Pharm. 2023. PMID: 36972778
  56. UVB modifies skin immune-stroma cross-talk and promotes effector T cell recruitment during cryptic Leishmania donovani infection. Paul M Kaye, et al. bioRxiv. 2023.
  57. An Image-Based Identification of Aggressive Breast Cancer Circulating Tumor Cell Subtypes. Mohamed Kamal, et al. Cancers (Basel). 2023. PMCID: PMC10216536
  58. Visualizing cell–cell communication using synthetic notch activated MRI. TianDuo Wang, et al. Proc Natl Acad Sci U S A. 2023. PMCID: PMC10089199
  59. Delivery of human adipose-derived stromal cells within in situ forming chitosan/PEG-PTMC hydrogels induces adverse outcomes in a femoral artery ligation model in athymic nu/nu mice. Lauren E. Flynn, et al. bioRxiv. 2023.
  60. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits. Alberto Sanchez-Aguilera, et al. Cancer Cell. 2023. PMCID: PMC10507426
  61. Protocol to generate murine organotypic brain cultures for drug screening and evaluation of anti-metastatic efficacy. Lucía Zhu, et al. STAR Protoc. 2023. PMCID: PMC10120397
  62. Adaptive rewiring of purine metabolism promotes treatment resistance in H3K27M-mutant diffuse midline glioma. Wahl DR, et al. Res Sq [Preprint]. 2023. PMCID: PMC10543500
  63. synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy. Kyle B Lupo, et al. Nat Commun. 2024. PMCID: PMC10907695
  64. Biohybrid microrobots locally and actively deliver drug-loaded nanoparticles to inhibit the progression of lung metastasis. Fangyu Zhang, et al. Sci Adv. 2024. PMCID: PMC11168470
  65. Macrophage-derived developmental endothelial locus 1 (DEL-1) expression promotes an immunoprotective phenotype in experimental visceral leishmaniasis. Jakub Lukaszonek, et al. bioRxiv. 2024.
  66. Radiation Synergizes with IL2/IL15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity. Xuefeng Li, et al. Mol Cancer Ther. 2024. PMID: 37956421
  67. GTP signaling links metabolism, DNA repair, and responses to genotoxic stress. Weihua Zhou, et al. Cancer Discov. 2024. PMCID: PMC10872631
  68. Humanized anti-CD11d monoclonal antibodies suitable for basic research and therapeutic applications. Eoin N Blythe, et al. Antib Ther. 2024. PMCID: PMC11744312
  69. Phosphoproteomic Profiling Reveals mTOR Signaling in Sustaining Macrophage Phagocytosis of Cancer Cells. Bixin Wang, et al. Cancers (Basel). 2024. PMCID: PMC11674635
  70. Amino Acid and Glucose Fermentation Maintain ATP Content in Mouse and Human Malignant Glioma Cells. Derek C Lee, et al. ASN Neuro. 2024. PMCID: PMC11792161
  71. Prostate Specific Membrane Antigen Expression in a Syngeneic Breast Cancer Mouse Model. Aditi A Shirke, et al. Mol Imaging Biol. 2024. PMCID: PMC11281974
  72. Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma. Wahl DR, et al. Cancer Metab. 2024. PMCID: PMC11003124
  73. Adipose-Derived Stromal Cells Delivered in Chitosan/PEG-PTMC Hydrogels Induce Adverse Outcomes in Nude Mice with Femoral Artery Ligation. Amsden BG, et al. GEN Biotechnology. 2024.
  74. Inhibition of H3K27M-enhanced ATM signaling increases radiation efficacy in diffuse midline glioma. Parsels JD, et al. bioRxiv. 2024.
  75. Sequence-based prediction of virus phenotype, evolutionary potential, and selective pressures. Chávez RAR, et al. The University of Iowa. 2024.
  76. CD47 Knock‑Out Using CRISPR‑Cas9 RNA Lipid Nanocarriers Results in Reduced Mesenchymal Glioblastoma Growth In Vivo. Nadia Rouatbi, et al. Adv Sci (Weinh). 2025. PMCID: PMC11948039
  77. The impact of a high fat diet and platelet activation on pre-metastatic niche formation. Marta Hergueta-Redondo, et al. Nat Commun. 2025. PMCID: PMC11965330
  78. Probing the effects of polysaccharide hydrogel composition on the viability and pro-angiogenic function of human adipose-derived stromal cells. Fiona E Serack, et al. J Biomed Mater Res A. 2025. PMID: 39304971
  79. CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation. Siqi Chen, et al. Nat Commun. 2025. PMCID: PMC12043996
  80. The SRG rat as a novel host for an orthotopic patient-derived xenograft model of breast cancer brain metastasis. Niveen Fulcher, et al. Sci Rep. 2025. PMCID: PMC12216210
  81. Characterization of Bone Marrow-Derived Immune Compartment in Murine Brain Metastases by Spectral Flow Cytometry. Ailen D Garcia-Santillan, et al. Methods Mol Biol. 2025. PMCID: PMC12281579
  82. STAT3 sustains tumorigenicity following mutant KRAS ablation. D’Amico S, et al. EMBO Rep. 2025. PMCID: PMC12549880
  83. A Site-Specific MiniAp4-Trastuzumab Conjugate Prevents Brain Metastasis. Masmudi-Martín M, et al. Mol Pharm. 2025. PMCID: PMC11881140
  84. Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemia. Zhang L, et al. Molecular Therapy. 2025.
  85. Surfaceome CRISPR activation screening uncovers ligands regulating tumor sensitivity to NK cell killing. Cong L, et al. Nat Commun. 2026. PMCID: PMC13538616
  86. Tumor cell dissemination is facilitated through regulatory T cell-driven extracellular matrix remodeling. Garcia-Santillan AD, et al. bioRxiv. 2025. PMCID: PMC12633443
  87. Enzymatic Cellular Nanoparticles Deliver Payloads across Mucosal Barriers. Zhang L, et al. Bioconjug Chem. 2025. PMID: 40675932
  88. Focused Ultrasound-mediated Disruption of Plasma Protein Binding Enhances Chemotherapeutic Effects of Paclitaxel on Xenografted Ovarian Cancer in Mice. SS Yoo, et al. Anticancer Research. 2025.
  89. Combined quetiapine and radiation therapy approach to treat mesothelioma-initiating cells and increase survival in a mouse model of mesothelioma. Cardenas A, et al. bioRxiv. 2025.
  90. A versatile platform for chemical engineering of exosomes empowered by ADP-ribosyl cyclases. Zhang L, et al. Nature Communications. 2025.
  91. Bi-directional highways and super-seeder tissues underpin parasite dissemination in experimental Leishmania donovani infection. Paul M Kaye, et al. Nature Communications. 2026.
  92. Investigating Trypanosoma cruzi infection and pathology following suppressive drug treatment. S Jayawardhana, et al.
  93. Lactate cannot replace glucose for maintaining the viability of mouse and human glioma cells. Ta NL, et al. bioRxiv. 2025.
  94. Innate Immune-Cloaked Microgel-Coated Mesenchymal Stromal Cells Reverse Persistent Pulmonary Fibrosis via Reparative Macrophages. Cho IS, et al. Adv Mater. 2026. PMID: 40984773
  95. PolyA tail segmentation improves the stability of the template DNA and increases the translatability of in vitro transcribed mRNA. Spiewla T, et al. Nucleic Acids Res. 2026. PMCID: PMC12805897
  96. Imaging CRISPR-edited CAR-T cell therapies with optical and positron emission tomography reporters. Sanchez-Pupo RE, et al. Theranostics. 2026. PMCID: PMC12846014
  97. ITGB1 Regulates Triple-Negative Breast Cancer Development by Modulating the Tumor Microenvironment. Song N, et al. Advanced Science. 2026.
  98. Quiescent tumor cells shape the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma. Matsui W, et al. Research Square.
  99. Activation of Thrombin Activatable Fibrinolysis Inhibitor by Thrombomodulin Attenuates Metastasis of Breast Cancer Cells. Reza T, et al. The University of Western Ontario. 2026.
  100. Implanted Dynamic Electric Field Therapy for Glioblastoma: Preclinical Safety and Efficacy of Intratumoral Modulation Therapy. Akbarzadeh AH, et al. Neuro-Oncology Advances. 2026.
  101. Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade glioma. Stopka SA, et al. Cell Reports Medicine. 2026.
  102. Comprehensive Mapping of the Virus and Host Factors that Guide the Paths of HIV-1 Escape from a Therapeutic. Haim H, et al. Cell Rep. 2026. PMID: 42322610
  103. Quiescent tumor cells shape the immunosuppressive microenvironment in pancreatic cancer. Matsui W, et al. Nat Commun. 2026. PMID: 42481500
  104. Human Decellularized Adipose Tissue Hydrogels as a Delivery Platform to Enhance Human Endothelial Colony-Forming Cell Retention and Vascular Regeneration. Terek AE, Walker JT, Bell GI, et al. Journal of Functional Biomaterials. 2026.
  105. FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells. Matsumoto M, Takayama R, Matsuguchi C, et al. European Journal of Pharmaceutical Sciences. 2026.
  106. USP15 regulates mitotic fidelity, metastatic potential, and chemotherapeutic response in ovarian cancer cells. Ogunsanya A, Alfaran F, Amadu ON, Padmanabhan A. Mol Ther Oncol. 2026. PMCID: PMC13571140
  107. Clinically Relevant Transplantable Tumor Models for Studying Metastatic Ovarian Cancer and Therapeutic Response in Mouse. Padmanabhan A. J Vis Exp. 2026. PMID: 42258493

Syd Labs D-荧光素钾盐(D-Luciferin Potassium Salt)引用文献及产品展示

D-荧光素钾盐的发光原理与实验配置指南

1. 生物发光机制

D-荧光素钾盐(D-Luciferin Potassium Salt)在三磷酸腺苷(ATP)和Mg²⁺存在条件下,被荧光素酶(Luciferase)催化氧化,生成激发态的氧代荧光素(Oxyluciferin),并在释放波长约 560 nm(体外)至 600 nm(体内,由于组织吸收和散射红移)的黄绿色荧光。由于哺乳动物内源性无生物发光背景,该系统具备极高的信噪比。

2. 小鼠活体成像配置与使用浓度

  • 储存母液配置:使用无菌无钙镁 PBS(pH 7.4)将 D-荧光素钾盐溶解配制成 15 mg/mL(约 47.1 mM)的母液。过滤除菌后,避光分装于 -20°C 或 -80°C 保存,避免反复冻融。
  • 小鼠注射剂量:按小鼠体重计算,标准腹腔注射(i.p.)剂量为 150 mg/kg(即每 20 g 体重小鼠注射 200 μL 的 15 mg/mL 溶液)。
  • 成像峰值窗口:腹腔注射后 10–20 分钟内荧光信号达到平台期,建议在此时间窗口内进行光学成像检测。

主流 D-荧光素钾盐 进口品牌选型参考

科研人员在进行实验室试剂采购时,可根据纯度、质量稳定度与性价比对比以下主流品牌:

  • Syd Labs D-荧光素钾盐 (MB102 / MB000102-R70170):高纯度(>99%),广泛应用于欧美科研核心平台,具备极高性价比与数百篇高分文献验证。
  • Goldbio D-荧光素钾盐 (LUCK-100):生命科学领域常用活体成像底物品牌。
  • PerkinElmer (PE) D-荧光素钾盐 (122799-100MG):小鼠成像仪(如 IVIS Spectrum)配套品牌。
  • Promega D-荧光素钾盐 (E1601-5mg):体外荧光素酶报告基因检测的经典品牌。
  • Biosynth D-荧光素钾盐 (L-8220) 与 Sigma D-荧光素钾盐 (50227-1mg):老牌生化试剂供应商。

技术支持与授权代理联系方式

如果您对 Syd Labs D-荧光素钾盐的实验配置、活体成像应用有任何技术疑问,或需要申请 Syd Labs 中国代理商 授权资质、确认代理真实性及进行服务反馈,欢迎联系多找找团队:

  • 企业微信:duozhaozhao2024
  • 联系电话:18162581039(龙经理)